Literature DB >> 26652841

Use of psychiatric medications in schizophrenia and other psychoses in a general population sample.

Salla Nykänen1, Virpi Puska1, Jussi-Pekka Tolonen1, Henri Salo1, Matti Isohanni2, Hannu Koponen3, Sami Pirkola4, Matti Penttilä1, Marianne Haapea5, Jani Moilanen6, Jouko Miettunen7, Erika Jääskeläinen8.   

Abstract

The information on the use of psychiatric medications in general population-based samples is limited. Our aim was to analyse the use of psychiatric medications and factors associated with antipsychotic use in psychoses in a general population sample. Fifty-five persons with schizophrenia, 21 with bipolar psychosis or psychotic depression and 20 with other psychoses from the Northern Finland Birth Cohort 1966 were examined at about 43 years of age. The frequency of use and dosage of psychiatric medication and the factors associated with the use of antipsychotics were analysed. Antipsychotics were used by 85% of schizophrenia, 65% of bipolar psychosis or psychotic depression and 62% of other psychoses cases; antidepressants were used by 22%, 60% and 33%; and benzodiazepines by 42%, 35% and 10%, respectively. In all the diagnostic groups, higher symptom scores and a higher number of hospital days were associated with the use of antipsychotics. In schizophrenia and other psychoses, poorer social and occupational functioning, and in other psychoses, female gender and lower education were also associated with the use of antipsychotics. Our results may partly indicate that, especially in schizophrenia, the effectiveness of antipsychotics is not as good as expected.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antipsychotic; Follow-up; Medication; Predictor; Psychosis; Treatment

Mesh:

Substances:

Year:  2015        PMID: 26652841     DOI: 10.1016/j.psychres.2015.11.013

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  2 in total

1.  Under-utilized opportunities to optimize medication management in long-term treatment of schizophrenia.

Authors:  Matti Isohanni; Jouko Miettunen; Erika Jääskeläinen; Jani Moilanen; Anja Hulkko; Sanna Huhtaniska
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

2.  Long-term Benzodiazepine Treatment in Patients with Psychotic Disorders Attending a Mental Health Service in Rural Greece.

Authors:  Vaios Peritogiannis; Thiresia Manthopoulou; Venetsanos Mavreas
Journal:  J Neurosci Rural Pract       Date:  2016-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.